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Dynamics of glomerular ultrafiltration following open-heart surgery.
To elucidate how individual determinants might lower the rate of
glomerular ultrafiltration (GFR) in some patients following cardiac
surgery, we performed hemodynamic measurements and clearances of
inulin (as a measure of GFR), PAH (as a measure of effective renal
plasma flow [ERPFD, and dextran-40. Two groups of 17 patients each
were distinguished by the presence or absence of prerenal azotemia.
Glomerular hypofiltration (GFR = 21 2 vs. 76 6mI/mini! .73 m2, P
<0.001) in the former was accompanied by depressed left ventricular
function, arterial pressure, and ERPF (152 26 vs. 317 32 mI/mini
1.73 m2, P < 0.001). To determine if factors beside ERPF play a role in
lowering GFR, we calculated the efferent oncotic pressure (ITe). Failure
of GFR to change over a 24-hour period despite increases in ERPF
suggested that both patient groups were at filtration pressure disequilib-
rium (FPD). This condition permits calculation of a unique glomerular
ultrafiltration coefficient (Kf). Over a range opressures for transcapil-
lary hydraulic pressure (P), such that 3 (AP — ii) 10 mm Hg (to
simulate FPD), Kf was less than 0.08 ml sec mm Hg 1.73 m2 in
azotemic, but exceeded this value in nonazotemic patients. Although a
selective reduction of Kf is predicted to lower the fractional clearance
of dextrans, these were significantly elevated in azotemic relative to
nonazotemic patients (molecular radii 30 — 40 A). A theoretical analysis
of the latter data suggests that over the foregoing range of FPD, a 15 to
30% decline in AP combined with a 30 to 0% reduction in Kf from
values in nonazotemic patients best explains the experimental findings
in azotemic patients.
Dynamique de Ia filtration glomerulaire aprês chirurgie a coeur ouvert.
Afin de savoir comment des determinants individuels peuvent abaisser
le debit de filtration glomérulaire (GFR) chez certains malades après
chirurgie cardiaque des mesures hémodynamiques et de clairances de
l'inulin (chez GFR), du PAH (chez ERPF) et du dextran-40 ont etC
rCalisées. Deux groupes de 17 malades chacun ont etC constituCs en
fonction de l'absence ou de Ia presence d'azotémie prC-renale. Dans le
premier groupe la baisse de GFR (21 2vs. 76 6 mllminll ,73 m2, P <
0,001) Ctait accompagnCe d'un abaissement de Ia fonction ventriculaire
gauche, de Ia pression artérielle et de ERPF (152 26 vs. 317 32 ml!
min!1,73 m2, P < 0,001). Afin de savoir si des fonctions autres que
ERPFjouent un role dans l'abaissement de GFR la pression oncotique
effCrente (Ire) aetC calculCe. Le fait que GFR n'ait pas change sur une
pCriode de 24 heures malgré des augmentations de ERPF suggCre que
les deux groupes de sujets Ctaient en situation de desCquilibre en cc qui
concerne Ia pression de filtration (FPD). Cette situation permet de
calculer un seul coefficient d'ultrafiltration glomCrulaire (Kf). Dans un
eventail de valeurs de la pression hydraulique transcapillaire (AP) tel
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que 3 (F — iTe) 10mm Hg (pour stimuler FPD), Kf Ctait infCrieur
a 0,08 ml sec mm Hg' 1,73 m2 chez les azotCmiques mais Ctait
supCrieur a cetta valeur chez les malades non azotCmiques. Alors
qu'une reduction selective de Kf devrait abaisser Ia clairance fraction-
nelle des dextrans, celle-ci Ctait significativement plus rande chez les
malades azotCmiques (diamétres molCculaires, 30 a 40 A). Une analyse
thCorique de ces resultats suggCre que dans l'Cventail des valeurs de
FPD deja mentionnC une dimunition de 15 a 30% de AP associCe a une
reduction de 30% de Kf par rapport aux malades non-azotCmiques est Ia
meilleure explication des constatations faites chez les malades azotC-
miques.
Between 2 and 7% of all patients undergoing open-heart
surgery develop acute renal failure (ARF) in the postoperative
period [1—5]. This lesion is thought to be hemodynamically
mediated and is characterized by a renal excretory failure that is
so profound and protracted that it necessitates dialysis therapy
in most cases [5, 6]. More common than intrinsic ARF, howev-
er, is a transient decline in renal function sufficient to produce
postoperative azotemia [1—3]. Studies of patients with this
milder lesion have revealed severe depression of the glomerular
filtration rate (GFR), sodium retention, and a persisting if
somewhat impaired ability to form a concentrated urine [5,
7—9]. Based on these findings, it has generally been regarded
that such transient postoperative azotemia represents a form of
prerenal failure.
To elucidate the pathogenesis of impaired postoperative renal
function, most investigators have focused their attention on the
surgical procedure and in particular on the period of cardiopul-
monary bypass (CPB) [7, 8, 10—13]. During CPB, the kidneys
are generally perfused at a pressure below the autoregulatory
range and at a flow below normal (200 to 500 mI/mm. [121). Not
surprisingly, GFR declines to low levels. Interpretation of
clearance data must, however, be treated with circumspection
because of hemodynamic instability, oliguria, and postoliguric
washout of clearance markers during CPB [8, 10]. In general,
protective measures adopted during surgery, including hypo-
thermia, a low hematocrit perfusate, and intermittent mannitol
administration, appear to be effective, and GFR returns toward
preoperative control values by the end of surgery [7, 8, 10—13].
Postoperative cardiac performance, on the other hand, clear-
ly an important determinant of renal function, has received
relatively little attention. Cardiac functional impairment is
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evident in most patients for one or more days following surgery
[14—161, and may be sufficiently severe to account for azotemia
of the prerenal type. Although scant information is available for
the renal response to poor cardiac function in surgical patients,
a large body of data has been amassed in nonsurgical patients
with cardiac diseases. Typically, renal vascular resistance rises
when the heart fails as a pump, but the rate of glomerular
ultrafiltration (GFR) is maintained within the normal range [17,
18], or it declines proportionately less than the fall in effective
renal plasma flow (ERPF) [18—22]. This tendency for the
filtration fraction to become elevated has generally been ob-
served in patients with well-compensated cardiac failure [17—20,
22]. Not infrequently, however, profound depression of GFR
associated with a low filtration fraction has been observed
where cardiac output was unusually low [19, 23, 24]. These
disparate trends for GFR and ERPF with varying grades of
cardiac functional impairment suggest that determinants of
glomerular ultrafiltration besides renal plasma flow may be-
come altered. With the successful application of micropuncture
techniques to several animal species, it has become apparent
that GFR is regulated by four determinants [25, 26]. Three are
hemodynamic and include glomerular plasma flow, afferent
oncotic pressure (ira), and the mean hydraulic pressure differ-
ence across the glomerular capillary wall (P). The remaining
determinant, the glomerular ultrafiltration coefficient (Kf), is
intrinsic to the glomerular capillary wall and is the product of
hydraulic permeability and surface area available for filtration.
To determine whether severe depression of GFR is associat-
ed with unusually poor cardiac performance in the early post-
cardiac operative period, we performed a simultaneous evalua-
tion of the hemodynamic and renal functional status of 34
patients. We then attempted to resolve whether glomerular
hypofiltration sufficient to cause azotemia in such patients
results solely from changes in some or all of the hemodynamic
determinants of GFR and whether alterations of the intrinsic
properties of the glomerular capillaries are contributory factors
as well.
Methods
Patient population and clinical background. Using a protocol
and consent procedure approved by the Committee on the Use
of Human Subjects in Research at Stanford University, we
selected 34 patients for study. All had undergone open-heart
surgery I to 4 days previously and had a serum creatinine
concentration of less than 2 mgldl on the day of operation. In 17
patients, serum creatinine was increasing at the time of study,
rising from an initial value of 1.5 0.1 mg/dl (mean SEM) to a
peak value of 3.0 0.7 mg/dl (P < 0.001). Corresponding values
for blood urea nitrogen concentration were 25 2 and 60 5
mg/dl, respectively. These patients comprise the azotemic
(experimental) group. In the remaining 17 patients, serum
creatinine concentration was 1.2 0.1 mg/dl on the operation
day and remained in the normal range. These latter patients
serve as the nonazotemic (control) group. All but three patients
in each group were male. Both groups were comprised of
patients of moderately advanced age, averaging 67 3 and 58
3 years in azotemic and nonazotemic patients, respectively.
Although azotemic patients tended to be older, and to have
higher initial serum creatinine levels, neither of these differ-
ences from the nonazotemic group reached statistical signifi-
cance.
Two criteria were used to ensure that azotemic patients did
not have ARF at the time of study. One was renal conservation
of sodium, defined as a fractional sodium excretion of 1% or
less [27]. The second criterion was the absence of transtubular
backleak of filtered inulin. Loss of tubular impermeability to
inulin is found in experimental animals during the first week of
postischemic acute renal failure [28—30], and may be recognized
in patients with ARF following open-heart surgery by perform-
ing simultaneous clearances of inulin and of larger dextran
molecules [6, 31]. These uncharged polysaccharide markers are
normally excreted by glomerular filtration and are neither
secreted nor reabsorbed [321. Inulin, which has an Einstein-
Stokes radius (ESR) of 13.5 A, is freely filtered, but restriction
to filtration is evident for dextran molecules with an ESR of 22
A or greater. In patients with postcardiac surgical ARF, howev-
er, the clearance of dextran molecules in the ESR range of 22 to
28 A frequently exceeds that of inulin, suggesting that the
smaller filtered inulin molecules are leaking back through
necrotic tubular epithelium at a more rapid rate than the larger
(filtered) dextran molecules do [6, 31]. Sodium-retaining azote-
mic patients were, therefore, included in the present study only
when the dextran-to-inulin clearance ratio was less than unity
for dextran molecules of ESR 22 A and greater, and when this
ratio decreased progressively with increasing molecular size.
Additional evidence that the renal injury was of a mild nature
was afforded by the observation that serum creatinine concen-
tration began to decline spontaneously before the end of the
first postoperative week in 14 of the 17 azotemic patients.
Operative and postoperative regimen. As judged by the
duration of the cardiopulmonary bypass (CPB), which averaged
161 16 and 140 13 mm in azotemic and nonazotemic
patients, respectively (P = NS), the magnitude of the surgical
procedure was similar in the two groups of patients. The
management of patients during CPB, and in the postoperative
period, details of which have been published elsewhere [51, was
also similar in the two groups of patients. In brief, CPB was
achieved with a nonpulsatile system using flow rates between
30 and 50 ml/minlkg and a perfusion pressure averaging 50 mm
Hg. Prior to and throughout CPB, all patients were volume
expanded with lactated Ringer's solution to which 12.5 g of 20%
mannitol was added every 60 mm. To maintain a high left atrial
filling pressure, we continued the volume expansion in the early
postoperative period. As judged by body weight at the time of
study, volume expansion averaged 15 and 11% of mean preop-
erative body weight in azotemic and nonazotemic patients,
respectively. In addition, vasodilator therapy with sodium
nitroprusside was administered to maintain systemic vascular
resistance in the normal range. Fourteen azotemic and thirteen
nonazotemic patients also required infusion of the inotropic
agent dopamine hydrochloride (6.9 0.9 and 7.9 1.1 pg/kg/
mm, respectively); and seven azotemic and nine nonazotemic
patients received therapy with an intraaortic balloon pump.
Study protocol. All studies were performed when patients
were hemodynamically stable. Sudden changes in blood vol-
ume, viscosity, and oncotic pressure were prevented by avoid-
ing infusion of packed red cells, hyperoncotic human albumin
solution, and diuretics for at least 6 hours prior to study when
clinically feasible. During each study, fluid balance was main-
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tamed by the infusion of isotonic dextrose or saline solution,
and the infusion rate of vasoactive drugs remained constant.
Radial arterial pressure, monitored via a saline-filled catheter
connected to a Hewlett-Packard pressure transducer (model HP
1280), fluctuated by less than 10 mm Hg in all studies.
Cardiac output was determined in duplicate by injection of
indocyanine green through a pulmonary arterial catheter, with
subsequent analysis by a Waters densitometer (model D-400)
and Waters cardiac output computer (model CO-4). The follow-
ing hemodynamic variables were derived:
Cardiac index (CI) was calculated as
CI = CO/BSA (1)
where CO is the measured cardiac output in liters/mm, and BSA
is the body surface area in m2.
Left ventricular stroke work index (SWI) was determined as
SW! = {[(MAP — LAP) x SVI] x (0.0l36)} (2)
where MAP is the mean arterial pressure and LAP is the mean
left atrial pressure in mm Hg; SVI is the stroke volume index,
and SWI is expressed as g m/m2 from the product of the
measured pressure difference and flow, and the factor 0.0136.
Systemic vascular resistance index (SVRI) was calculated as
SVRI = (MAP — CVP)/CI
where CVP is the central venous pressure in mm Hg, and the
resistance index is expressed in Wood units/m2.
Following a priming injection of inulin (24 mg/kg) paraamino-
hippurate (3.5 mg/kg) and dextran-40 (130 mg/kg), we adminis-
tered inulin and PAH at a rate calculated to maintain plasma
inulin and PAH concentrations constant at 10 to 15 and 1.0 to
1.5 mg/dl, respectively. After a 60-mm equilibration period,
three 20-mm urine collections were made through an indwelling
Foley catheter. Arterial blood was drawn from the radial
arterial line to bracket each collection. Clearances of inulin
(GFR) and PAH (ERPF) and the fractional excretion of sodium
were calculated [6, 31]. Fractional clearances of dextran (OD)
were determined from plasma and urine obtained during the
first timed collection period, using the equation
= (U/P)D / (U/P)1
where (U/P)D and (U/P)1 refer to the urine-to-plasma concen-
tration ratios of dextran and inulin, respectively. Plasma protein
concentration and plasma oncotic pressure were determined
from the 60-mm blood sample.
Determination of the glomerular ultrafiltration coefficient
(Kf). Using a mathematical model of glomerular ultrafiltration
described previously [33] and developed and verified, in part,
by one of us (CRR), an attempt was made to estimate a range of
values for the glomerular membrane ultrafiltration coefficient
(Kf) in each of the patient groups. To do this, we had to obtain
the afferent and efferent arteriolar plasma protein concentra-
tions, Ca and Ce, respectively, the preglomerular plasma flow
rate (approximated by PAH clearance), and the average trans-
membrane (glomerular) hydraulic pressure difference, LP. Ce
was calculated from the filtration fraction (inulin clearance/
PAH clearance, FF) and from Ca using the relation:
Ce = Ca/(1FF)
(3)
A value for efferent plasma oncotic pressure (ire) was then
derived from Ce using the relation [33]:
iTe = aiCe + a2Ce2 (6)
where a1 = 1.629 mm Hg/g% and a2 0.2935 mm Hg/g%.
The correlation was verified for use in man by measuring IT
with a membrane osmometer over the range of efferent plasma
protein concentrations encountered in this study (6 <Ce < 9 g/
dl). In doing so, it was found that Eq. 6 is accurate to within 2%
over this concentration range.
Because cannot be determined in man, values ranging
from 0.1 (AP — ire) 10 mm Hg were examined for each
experimental group. The lower bound for AP was chosen to
approximate conditions of filtration pressure equilibrium, that
is, when AP and the opposing intraglomerular oncotic pressure
become equal at some point in the glomerular capillary network
proximal to its efferent end. Filtration pressure equilibrium is
typical of species such as the Munich-Wistar rat and squirrel
monkey in which glomerular plasma flow is normally less than
160 nI/mm [34, 35]. In the human kidney containing two million
glomeruli, ERPF averages 600 ml/min [361. Average glomerular
plasma flow, therefore, is high, averaging 300 nl/min. At
similarly high glomerular plasma flows in the dog, filtration
pressure equilibrium is not achieved and exceeds oncotic
pressure at the efferent end of the glomerular capillary network
by 7 to 12 mm Hg [37—39]. The upper bound for AP in this study
was accordingly selected to match the level of canine filtration
pressure disequilibrium.
Renal plasma flow may be profoundly depressed in the
presence of a low cardiac output state and might fall into a range
consistent with the attainment of filtration pressure equilibrium.
If, however, severe depression of ERPF is also accompanied by
a decline in Kf, filtration pressure equilibrium might not be
achieved [26]. In the aforementioned mammalian species, filtra-
tion pressure equilibrium is associated with a striking degree of
dependence of GFR on renal plasma flow. We therefore as-
sessed the presence of filtration pressure equilibrium by mea-
suring the change in GFR in response to spontaneous alter-
ations of ERPF. Accordingly, inulin and PAH clearances were
f4 repeated 24 hours after the initial study in 7 patients from each
group.
Laboratory methods. For the calculation of GFR, inulin
concentration in urine and plasma was determined using the
autoanalyzer method of Fjeldbo and Stamey [40]. This method
uses the fructose-specific reagent resorcinol, which is influ-
enced by the presence of dextran. The autoanalyzer method of
Harvey and Brothers was used for the determination of PAH
[411.
Separation of dextran-40 and inulin in plasma and urine into
narrow fractions (approximately 2 A) was accomplished by gel
permeation chromatography with Sephacryl S200. Two col-
umns, 91 and 95 cm in length with internal diameters of 1.6 cm,
were used. Each column was calibrated with three narrow
dextran fractions of known molecular size (Pharmacia Fine
Chemicals AB, Uppsala, Sweden). Using 0.3% buffered saline
as eluent, we collected eluted fractions of 2.6 ml each, with an
automatic fractionator (Gilson model S-80). The void volume
(V0) was determined with Blue Dextran, and the fractional
(5) volume available to the solute (Kay) was calculated as
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Table 1. Postoperative hemodynamic and clearance dataa
I I
• Azotemic
o Nonazotemic
8.91x — 4.47
= 0.69
80
#.o7o
0 :
60 0
40
20 • • •r= 0.30
• .
I I
'O 1.00 2.00 3.00
Kay = (Ye — Y0)/(Y — V0)
where Ve is the elution volume of the solute and Vt the total
volume of the gel column [42]. Einstein-Stokes radii (ESR) for
individual dextran fractions were calculated from Kay [43].
Following gel-permeation chromatography of plasma and
urine, eluted fractions were assayed for dextran and inulin
concentrations using a modification of the autoanalyzer an-
throne method of Scott and Melvin [44]. Plasma oncotic pres-
sure was determined with an IL 186 Weil oncometer, and
plasma total protein concentration with a standard Biuret
technique.
Statistical methods. Data for each patient group were ana-
lyzed by means of the Statistical Package for the Social
(7) Sciences [45]. A two-tailed student's t test with separate
variance estimates was used to test the significance of the
differences observed. To determine the significance of change
in clearance values overtime, we performed statistical compari-
son to the first study using a two-tailed t test for paired data
(SPSS) [45]. All results are expressed as the mean and the SEM.
Results
Hemodynamic findings (Table 1). The hemodynamic findings
for each of the two patient groups are summarized in Table 1.
Systemic vascular resistance was successfully lowered into the
normal range by sodium nitroprusside in both patient groups,
averaging 26.2 2.0 and 25.8 2.7 Wood units/rn2 in nonazote-
mic and azotemic patients, respectively. Volume expansion
Nonazotemic
(N=17)group
Azoternic
(N=17)group P
SVRI, Wood units/rn2 26.2 2.0 25.8 2.7 NS
CI, liters/min/m 2.78 0.16 2.46 0.18 NS
SWI, g rn/rn2 27.8 2.9 14.4 1.5 <0.001
LAP, mm Hg 20 2 27 2 <0.01
MAP, mm Hg 87 4 76 2 <0.02
Heart rate, beats/mm 95 2 98 3 NS
FENa, % 1.0 0.3 0.4 0.1 <0.05
Volume expansion, % 10.5 1.4 15.3 2.0 <0.02
ERPF, ml/min/J.73 m2 317 32 152 26 <0.001
GFR, ml/min/1.73 m2 76 6 21 2 <0.001
Filtration fraction 0.25 0.02 0.16 0.02 <0.001
ha, mm Hg 20.8 0.5 21.4 0.7 NS
iTe, mm Hg 33.0 0.9 28.7 1.3 <0.02
Values are expressed as mean SEM. SVRI is systemic vascular resistance index; CI, cardiac index; SWI, left ventricular stroke work index;
LAP, left atrial pressure; MAP, mean arterial pressure; ERPF, effective renal plasma flow; lTa and ite, afferent and efferent arteriolar oncotic
pressure.
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Fig. 1. Relationship between GFR andcardiac index in nonazotemic (0)
and azotemic (•) postoperative patients.
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Fig. 2. Relationship between GFR and effective renal plasma flow in
nonazotemic (0) and azotemic (•) postoperative patients.
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Fig. 5. Theoretical analysis of the effects of a reduction in PAH
extraction on the glomerular ultrafiltration coefficient in azoteinic
patients. The lower curve was calculated using PAH clearance as a
measure of renal plasma flow. For the middle and upper curves, renal
plasma flow was calculated assuming a PAH extraction ratio of 0.7 and
0.5, respectively.
resulted in a high left ventricular filling pressure, which, as
judged by mean pulmonary arterial diastolic pressure, was
significantly higher in the azotemic group (27 2 mm Hg) than
in the nonazotemic group (20 2 mm Hg, P <0.01). Notwith-
standing this successful manipulation of cardiac preload and
afterload, nonazotemic patients still manifested a mild low
cardiac output state, as judged by a cardiac index of 2.78 0.16
liters/min/m2 on the average (normal, 2.8 to 4.2 liters/min/m2
[461). Similarly, a mean left ventricular stroke work index of
27.8 2.9 g mIm2 (normal, 30 to 100 g rn/rn2 [46]) reflects
depression of the left ventricular function curve. By compari-
son, profound depression of cardiac function and a severe low
cardiac output state characterized azoternic patients. Cardiac
index was depressed to 2.46 0.18 liters/min/m2, and left
ventricular stroke work index was extremely depressed to 14.4
1.5 g rn/rn2, a value lower than that in nonazoternic patients
(P < 0.001).
Mean arterial pressure averaged 87 4 mm Hg in nonazote-
mic patients, but was at the lower end of the autoregulatory
range in azoternic patients, averaging 76 2 mm Hg (P < 0.02).
The renal hemodynamic response in each group was character-
ized by a depression of ERPF and a blunting of urinary sodium
excretion. Effective renal plasma flow was more depressed in
azotemic than it was in nonazoternic patients, averaging 152
26 vs. 317 32 ml/min/l.73 m2 (P < 0.001). Notwithstanding
volume expansion, which resulted in a weight gain of 11 1%
in nonazotemic patients and 15 2% in azotemic patients,
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Fig. 3. Effects on GFR (left panel) of spontaneous increases in effective
renal plasma flow (middle panel), in nonazotemic (0) and azotemic (•)
postoperative patients. Change in filtration fraction is illustrated in right
panel. t = P < 0.1, * = P <0.05, ** = P <0.005, NS = not significant.
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Fig. 4. Calculated glomerular ultrafiltration coefficient (KI) for values
of mean transcapillary hydraulic pressure difference (L.P) exceeding
efferent oncotic pressure (ire) by I to 10 mm Hg. In nonazotemic
patients, indicated by an open circle (0), absolute values for P vary
from 34 to 43 mm Hg. In azotemic patients, indicated by a closed circle
(•), absolute values for P vary from 30 to 39 mm Hg.
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Table 2. Fractional dextran clearancesa
Em stein-Stokes radius, A
20 22 24 26 28 30 32 34 36 38 40 42 44 46
Nonazotemic group (N = 17)
Azotemic group (N = 17)
p
0.99
0.99
NS
0.94
0.95
NS
0,87
0.90
NS
0.81
0.89
NS
0.73
0.81
NS
0.65
0.74
<0.05
0.55
0.67
<0.01
0.45
0.57
<0.005
0.35
0.46
<0.005
0.29
0.37
<0.01
0.22
0.29
<0.02
0.17
0.21
NS
0.12
0.15
<0.05
0.09
0.11
NS
a Values are the means SEM.
fractional sodium excretion averaged only 1.0 0.3 and 0.4
0.1% (P < 0.05), respectively.
Dynamics and determinants of glomerular ultrafiltration
(Table 1, Figs. 1—4). The GFR varied widely in nonazotemic
patients, ranging from 37 to 132 ml/min/1.73 m2. The mean
value of 76 6 ml/min/1.73 m2 was significantly higher than that
in azotemic subjects in whom GFR averaged 21 2 mI/mm/I .73
m2 (P < 0.001). Similarly, the filtration fraction was higher in
the nonazotemic group, averaging 0.25 0.02 vs. 0.16 0.02 in
azotemic patients (P < 0.001). Given the higher filtration
fraction and a value for Ira that was not different from that in the
azotemic group (20.8 0.5 vs. 21.4 0.7 mm Hg, respective-
ly), the calculated value for mean iTe of 33.0 0.9 mm Hg in
nonazotemic patients was significantly elevated above that in
azotemic patients (28.7 1.3 mm Hg, P < 0.02).
The GFR appeared to reflect the hemodynamic status of
nonazotemic patients. As shown in Figs. 1 and 2, GFR was
highly correlated with cardiac index (r = 0.69, P < 0.002) and
ERPF (r = 0.82, P < 0.001). In contrast, there was no
correlation between GFR and cardiac index in azotemic pa-
tients (r 0.30, P = NS), and GFR was less well correlated
with ERPF (r = 0.56, P < 0.01) than it was in nonazotemic
patients. Despite the significant correlation between GFR and
ERPF in both patient groups, GFR was not highly plasma-flow
dependent. In 14 patients who were reexamined 24 hours after
the initial study, ERPF had increased uniformly whereas, with
one exception, GFR increased proportionately less or actually
declined. In 7 nonazotemic patients, ERPF increased by 32%
from 254 40 to 336 49 ml/mjn/1.73 m2 (P < 0.005).
Similarly, ERPF in 7 azotemic patients increased by 23% from
138 28 to 170 33 ml/min/l.73 m2 (P < 0.005). In contrast,
the mean GFR remained unchanged (68 4 and 70 12 ml/min!
1.73 m2 in nonazotemic patients and 24 3 and 25 5 mI/mini
1.73 m2 in azotemic patients). The failure of GFR to increase in
proportion to ERPF is reflected by a 23% and 15% reduction in
filtration fraction in nonazotemic and azotemic patients, respec-
tively (Fig. 3).
The results of Kf over a range of values 1 mm Hg  (P — lie)
 10 mm Hg are illustrated in Fig. 4. Over this entire range in
nonazotemic patients (zP = 34 to 43 mm Hg), Kf never fell
below 0.08 ml sec' ' mm Hg' 1.73 m2. In contrast, Kf
exceeded 0.08 ml sec' mm Hg' 1.73 m2 in azotemic
patients with severe cardiac failure only when P was within 2
mm Hg of ire. Given the poor correlation between GFR and
ERPF, and the failure of GFR to rise in response to spontane-
ous increases in ERPF, it seems likely that, despite severe
reduction in ERPF, these latter patients were not at or close to
filtration pressure equilibrium. It is important to note, there-
fore, that for values of 3 mm Hg (i — ire) 10 mm Hg (that
is, zP = 32 to 39 mm Hg), Kf in azotemic patients fell
substantially below 0.08 ml ' sec1 mm Hg 1.73 m2.
Many of the input values in our ultrafiltration model are
derived from the rate of renal plasma flow, which was deter-
mined from the clearance of PAH. Because the ability of the
proximal tubule cell to secrete PAH may become impaired in
the presence of severe renal ischemia, we have examined the
effects of reduced PAH extraction on the computed values for
Kf in the azotemic patient group. The results of these computa-
tions are compared with those obtained with PAH clearance
(lower curve) in Fig. S. As shown, an assumed reduction of the
PAH extraction ratio to 0.7 or 0.5 with appropriate correction of
the rate of renal plasma flow, has relatively little effect on the
calculated value for Kf. This is particularly true over the range
of values consistent with filtration pressure disequilibrium
(3 mm Hg [P — lie] 10mm Hg) in which Kf remains below0.08 ml sec mm Hg' . 1.73 m2, even when the PAH
extraction ratio is reduced to 0.5.
Urinary dextran clearances (Table 2, Fig. 6). The fractional
clearance values for dextrans relative to inulin (On) in each
patient group are plotted as a function of ESR in Fig. 6.
Measurable restriction to dextran (indicated by eD<l) oc-
curred when ESR> —22 A. With increasing molecular size, )D
declined and approached a value of 0.10 for dextrans with an
ESR of 46 A. The values for 0D in nonazotemic patients were
similar to those reported by us previously for healthy adult
volunteers [31]. For molecules of equivalent size, 0D tended to
be elevated in azotemic relative to nonazotemic patients. This
elevation was highly significant and most striking (27 to 32%)
over the ESR range 32 to 40 A (Table 2). For molecules of
smaller or larger size, the elevation of O in azotemic relative to
nonazotemic patients was less than 20% and in most instances
failed to achieve statistical significance.
Discussion
The rate of glomerular ultrafiltration in patients who did not
become azotemic following cardiac surgery was highly correlat-
ed with cardiac performance (Fig. 1). Under the conditions of
moderate cardiac functional impairment that obtained in these
patients, GFR was in or close to the range expected for normal
subjects of this age. As judged by a filtration fraction of 0.25
0.02, which is higher than that found in normal subjects (0.18 to
0.20 [47]), GFR declined proportionally less than ERPF did. A
similar response has been documented in patients with stable
valvular heart disease [17—19, 21, 22] and has been attributed to
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Fig. 6. Fractional dextran clearance profiles in nonazotemic (0) and
azotemic (•) postoperative patients. Results are expressed as the means
SEM. * = P < 0.05; ** = P < 0.005.
a compensatory increase in glomerular ultrafiltration pressure
[48]. Assuming that ERPF was equally distributed among all
two million glomeruli in each patient, mean glomerular plasma
flow would approximate 160 nllmin, a flow rate at which
filtration pressure equilibrium is unlikely to be achieved [25, 26,
38]. Indirect evidence that filtration pressure disequilibrium
obtained in these patients is provided by the failure of GFR to
increase in proportion to spontaneous increases in ERPF (Fig.
3) It is interesting to note, therefore, that an assigned range of
values for zP in excess Of 'rre by 3 to 10mm Hg (or P = 36 to 43
mm Hg) yielded a value for Kf of between 0.08 and 0.16 ml
sec mm Hg 1.73 m2 (Fig. 4). This range of values
corresponds to an average Kf per glomerulus of 0.04 to 0.08 nl
sec mm Hg' and is quite similar to that obtained by more
direct methods in all mammalian species examined to date [26,
35, 37, 49].
By contrast, cardiac performance and GFR were poorly
correlated in azotemic patients. The severe low cardiac output
state was accompanied by depression of GFR to a value, 21 2
ml/min/1 .73 m2, corresponding to only 28% of that in nonazote-
mic controls. In attempting to elucidate the mechanism of the
profound glomerular hypofiltration observed in these patients,
it is useful to consider the relative contribution of each of the
determinants of GFR.
As judged by PAH clearance, ERPF, an important determi-
nant of GFR [25], was depressed to 48% of that in nonazotemic
controls. Reduced renal plasma flow, therefore, presumably
played a role in lowering GFR. It could be argued that the
severe renal ischemia observed in azotemic patients might
impair PAH extraction by the kidney, and that PAH clearance
may, in fact, provide an underestimate of ERPF. Earlier studies
of patients with low cardiac output states, however, have
invariably demonstrated PAH extraction to be normal despite
significant elevation of renal vascular resistance [18—20, 22].
Nevertheless, because no attempt was made by us to directly
estimate PAH extraction in these critically ill patients, we
cannot exclude the possibility that ERPF may have been higher
than suggested by the PAH clearance. It is important to point
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Fig. 7. Percent reduction in L,.P and Kf from values in nonazotemic
patients required to elevate the fractional dextran clearance profile to
levels observed in azoternic patients at the measured values of ERPF
and i in the latter group. The stippled zone incorporates the percent
declines for P and Kf needed for selected values of in nonazotemic
patients between 35 (right-hand side) and 46 mm Hg (left-hand side),
respectively. F.P. denotes filtration pressure.
out, therefore, that in such an event, the value of filtration
fraction in azotemic subjects would be even lower than the 0.16,
suggested by the inulin-to-PAH clearance ratio, and below that
found in normal subjects [47]. Under the conditions of filtration
pressure disequilibrium, which appear to have obtained in these
patients (Fig. 3), had values for the remaining determinants of
GFR been the same as those in nonazotemic controls, a
selective reduction in ERPF would be predicted to result in a
higher and not a lower filtration fraction [25]. One or more of
the remaining determinants of GFR must therefore have
changed simultaneously with the depression of ERPF.
Afferent oncotic pressure in this study was measured directly
with a membrane osmometer. The average value of 21 mm Hg is
similar to that reported by Weil et a! for normal subjects at
bedrest [50]. More importantly, ir was not different between
the two patient groups and cannot be invoked, therefore, to
explain the observed differences in GFR and filtration fraction.
By exclusion, these differences appear to be attributable to
reductions in either P or Kf alone, or in some combination
thereof. Such reduction in either P and/or Kf must be consis-
tent with the measured urinary fractional dextran clearances
shown in Fig. 6, in particular, the elevated fractional clearances
seen in azotemic relative to nonazotemic patients.
It is recognized that transcapillary solute exchange in the
renal glomerulus is governed, in part, by the same determinants
that control the ultrafiltration process, namely, AP, ERPF, Ira,
and Kf [51, 52]. For neutral solutes, membrane permselectivity
is also dependent on molecular size and shape as well as on an
intrinsic membrane transport parameter (for example, pore size
or pore density) [51]. Because glomerular morphology remains
unaltered in the presence of cardiac failure [53, 54], we assumed
that pore size remains unchanged in the two patient popula-
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lions. We then used a theoretical model of transcapillary solute
exchange based on a hydrodynamic theory of transport of
neutral macromolecules through an uncharged isoporous mem-
brane [511. From this theoretical model, it is possible to
compute the magnitude of the reductions in iW and Kf, which
are consistent not only with the measured values of ERPF and
Ira, but also with the fractional clearance profiles for neutral
dextran shown in Fig. 6. The results of such computations are
presented in Fig. 7, which shows the percent declines in P and
Kf needed to elevate the fractional dextran clearance profile
from the mean of that observed in the nonazotemic patients to
the mean 1 SEM of that observed in the azotemic patients.
Although inferred but not explicitly indicated in Fig. 7, reduc-
tions in Kf alone cannot account for the elevation in °D seen in
azotemic patients relative to the nonazotemic group. Indeed,
reductions in Kf without concomitant reductions in zP always
result in a lowering of e, not an elevation of O as was
observed. In contrast, a selective reduction by 30% of zP from
values of approximately 46mm Hg (that is, AP lie l3mm
Hg) with essentially no change in Kf would be consistent with
the observations. As shown in Fig. 7, smaller reductions in P
from values within 5 mm Hg of filtration pressure equilibrium
require, at most, a concomitant 30% reduction in Kf. Because
GFR in azotemic patients was not sensitive to changes in
ERPF, it may be inferred that these patients were not at
filtration pressure equilibrium and that the values at the right
hand extreme of the calculated zone are unlikely to have
obtained (that is, percent declines in Kf exceeding approximate-
ly 30%). Put another way, the observed increase in the fraction-
al clearances of dextrans in azotemic patients seems to be best
explained by a reduction of J5 to a value between 30 and 15%
below that in nonazotemic patients with a corresponding reduc-
tion in the value for Kf of between 0 and 30%, respectively. The
greater the degree of filtration pressure disequilibrium obtain-
ing, the larger is the contribution of iP relative to Kf reduction.
Although our findings are of necessity based on an indirect
approach and are not entirely conclusive, we would suggest that
GFR in the postoperative period following open-heart surgery is
a function of cardiac performance. When impairment of cardiac
performance is moderate, as in our nonazotemic patients, GFR
falls less than in proportion to ERPF, possibly as a result of a
compensatory increase in zW. Below some critical level of
cardiac function, as in our azotemic patients, this compensatory
mechanism fails, and GFR and filtration fraction become se-
verely reduced. A reduction in P, probably in combination
with reduced Kf, appears to lower GFR disproportionately to
the accompanying depression of ERPF.
Direct measurements in the normal Munich-Wistar rat have
revealed that at arterial pressures above 90 mm Hg, P (like
renal blood flow) is autoregulated by a resetting of the resis-
tances in afferent and efferent arterioles [55]. At values of
arterial pressure below 90 mm Hg, however, zP has been
shown to decline in both the rat and the dog [38, 551. In keeping
with these findings, it may be that P in azotemic patients
declined as a consequence of the relative arterial hypotension
associated with the low cardiac output state (MAP = 76 2 mm
Hg, Table 1). Inasmuch as arterial hypotension may be attribut-
ed in part to the use of sodium nitroprusside infusion in these
patients, the role of aggressive afterload reduction in low output
cardiac failure merits review. It may be that the advantage of
increasing cardiac output by this technique is offset by a
profound decline in GFR when arterial pressure is allowed to
fall below the autoregulatory range. We suggest that under such
circumstances it would be prudent to monitor GFR while
permitting arterial pressure to rise by reducing or withholding
the infusion of vasodilator agents.
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